These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

235 related articles for article (PubMed ID: 25965667)

  • 1. MALT1 Protease Activity Is Required for Innate and Adaptive Immune Responses.
    Yu JW; Hoffman S; Beal AM; Dykon A; Ringenberg MA; Hughes AC; Dare L; Anderson AD; Finger J; Kasparcova V; Rickard D; Berger SB; Ramanjulu J; Emery JG; Gough PJ; Bertin J; Foley KP
    PLoS One; 2015; 10(5):e0127083. PubMed ID: 25965667
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Deficiency of MALT1 paracaspase activity results in unbalanced regulatory and effector T and B cell responses leading to multiorgan inflammation.
    Bornancin F; Renner F; Touil R; Sic H; Kolb Y; Touil-Allaoui I; Rush JS; Smith PA; Bigaud M; Junker-Walker U; Burkhart C; Dawson J; Niwa S; Katopodis A; Nuesslein-Hildesheim B; Weckbecker G; Zenke G; Kinzel B; Traggiai E; Brenner D; Brüstle A; St Paul M; Zamurovic N; McCoy KD; Rolink A; Régnier CH; Mak TW; Ohashi PS; Patel DD; Calzascia T
    J Immunol; 2015 Apr; 194(8):3723-34. PubMed ID: 25762782
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The paracaspase MALT1 cleaves HOIL1 reducing linear ubiquitination by LUBAC to dampen lymphocyte NF-κB signalling.
    Klein T; Fung SY; Renner F; Blank MA; Dufour A; Kang S; Bolger-Munro M; Scurll JM; Priatel JJ; Schweigler P; Melkko S; Gold MR; Viner RI; Régnier CH; Turvey SE; Overall CM
    Nat Commun; 2015 Nov; 6():8777. PubMed ID: 26525107
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MALT1--a universal soldier: multiple strategies to ensure NF-κB activation and target gene expression.
    Afonina IS; Elton L; Carpentier I; Beyaert R
    FEBS J; 2015 Sep; 282(17):3286-97. PubMed ID: 25996250
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MALT1 cleaves the E3 ubiquitin ligase HOIL-1 in activated T cells, generating a dominant negative inhibitor of LUBAC-induced NF-κB signaling.
    Elton L; Carpentier I; Staal J; Driege Y; Haegman M; Beyaert R
    FEBS J; 2016 Feb; 283(3):403-12. PubMed ID: 26573773
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of Malt1 protease activity in pathogenesis of inflammatory disorders mediated by FcγR signaling.
    Nakamura Y; Yokoyama K; Igaki K; Tsuchimori N
    Int Immunopharmacol; 2018 Mar; 56():193-196. PubMed ID: 29414650
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Uncoupling Malt1 threshold function from paracaspase activity results in destructive autoimmune inflammation.
    Gewies A; Gorka O; Bergmann H; Pechloff K; Petermann F; Jeltsch KM; Rudelius M; Kriegsmann M; Weichert W; Horsch M; Beckers J; Wurst W; Heikenwalder M; Korn T; Heissmeyer V; Ruland J
    Cell Rep; 2014 Nov; 9(4):1292-305. PubMed ID: 25456129
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A20 negatively regulates T cell receptor signaling to NF-kappaB by cleaving Malt1 ubiquitin chains.
    Düwel M; Welteke V; Oeckinghaus A; Baens M; Kloo B; Ferch U; Darnay BG; Ruland J; Marynen P; Krappmann D
    J Immunol; 2009 Jun; 182(12):7718-28. PubMed ID: 19494296
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Malt1 protease inactivation efficiently dampens immune responses but causes spontaneous autoimmunity.
    Jaworski M; Marsland BJ; Gehrig J; Held W; Favre S; Luther SA; Perroud M; Golshayan D; Gaide O; Thome M
    EMBO J; 2014 Dec; 33(23):2765-81. PubMed ID: 25319413
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Selective C-Rel activation via Malt1 controls anti-fungal T(H)-17 immunity by dectin-1 and dectin-2.
    Gringhuis SI; Wevers BA; Kaptein TM; van Capel TM; Theelen B; Boekhout T; de Jong EC; Geijtenbeek TB
    PLoS Pathog; 2011 Jan; 7(1):e1001259. PubMed ID: 21283787
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MALT1 Proteolytic Activity Suppresses Autoimmunity in a T Cell Intrinsic Manner.
    Demeyer A; Skordos I; Driege Y; Kreike M; Hochepied T; Baens M; Staal J; Beyaert R
    Front Immunol; 2019; 10():1898. PubMed ID: 31474984
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MALT1 Protease Activity Controls the Expression of Inflammatory Genes in Keratinocytes upon Zymosan Stimulation.
    Schmitt A; Grondona P; Maier T; Brändle M; Schönfeld C; Jäger G; Kosnopfel C; Eberle FC; Schittek B; Schulze-Osthoff K; Yazdi AS; Hailfinger S
    J Invest Dermatol; 2016 Apr; 136(4):788-797. PubMed ID: 26767426
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Normal lymphocyte homeostasis and function in MALT1 protease-resistant HOIL-1 knock-in mice.
    Skordos I; Driege Y; Haegman M; Kreike M; Staal J; Demeyer A; Beyaert R
    FEBS J; 2023 Apr; 290(8):2032-2048. PubMed ID: 36479846
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interplay between BCL10, MALT1 and IkappaBalpha during T-cell-receptor-mediated NFkappaB activation.
    Carvalho G; Le Guelte A; Demian C; Vazquez A; Gavard J; Bidère N
    J Cell Sci; 2010 Jul; 123(Pt 14):2375-80. PubMed ID: 20551178
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CARD-Bcl10-Malt1 signalosomes: missing link to NF-kappaB.
    Wegener E; Krappmann D
    Sci STKE; 2007 May; 2007(384):pe21. PubMed ID: 17473310
    [TBL] [Abstract][Full Text] [Related]  

  • 16. PDK1 nucleates T cell receptor-induced signaling complex for NF-kappaB activation.
    Lee KY; D'Acquisto F; Hayden MS; Shim JH; Ghosh S
    Science; 2005 Apr; 308(5718):114-8. PubMed ID: 15802604
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Paracaspase MALT1.
    Hachmann J; Salvesen GS
    Biochimie; 2016 Mar; 122():324-38. PubMed ID: 26386283
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Two Antagonistic MALT1 Auto-Cleavage Mechanisms Reveal a Role for TRAF6 to Unleash MALT1 Activation.
    Ginster S; Bardet M; Unterreiner A; Malinverni C; Renner F; Lam S; Freuler F; Gerrits B; Voshol J; Calzascia T; Régnier CH; Renatus M; Nikolay R; Israël L; Bornancin F
    PLoS One; 2017; 12(1):e0169026. PubMed ID: 28052131
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular pathways: targeting MALT1 paracaspase activity in lymphoma.
    Fontán L; Melnick A
    Clin Cancer Res; 2013 Dec; 19(24):6662-8. PubMed ID: 24004675
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MALT1 protease: a new therapeutic target in B lymphoma and beyond?
    McAllister-Lucas LM; Baens M; Lucas PC
    Clin Cancer Res; 2011 Nov; 17(21):6623-31. PubMed ID: 21868762
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.